Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

Phase 4 Completed 19 enrolled Fougera Pharmaceuticals Inc.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of Pandel® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area.

Timeline

Start: 2004-06
Primary completion: 2005-08
Completion: 2005-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	hydrocortisone probutate	Small molecule	0.1 %	Topical

Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

Summary

Timeline

Drugs

Indications